The Latest Proteomics Industry Statistics Explained
Global proteomics market size was valued at USD 13.49 billion in 2019.
This statistic indicates that the total market size of global proteomics, which refers to the large-scale study of proteins in biological systems, was valued at USD 13.49 billion in 2019. This figure represents the aggregate value of the products, services, and research activities within the proteomics industry worldwide during that year. Such a valuation reflects the significant investment and growth opportunities in proteomics research, driven by advancements in technology, increasing applications in various fields such as drug discovery and personalized medicine, and rising demand for understanding complex biological processes at the protein level. The market size serves as a key indicator of the economic significance and potential impact of proteomics on various scientific and commercial sectors.
Proteomics market size is expected to reach USD 49.97 billion by 2030.
The statistic indicates that the proteomics market is projected to grow substantially and reach a total value of USD 49.97 billion by the year 2030. This forecast suggests a significant increase in the demand for proteomics technologies, products, and services over the next decade. Factors driving this growth may include advancements in proteomic research, the rising prevalence of chronic diseases, increasing investments in healthcare R&D, and a growing focus on personalized medicine. The projected market size signifies a promising outlook for the proteomics industry, with opportunities for companies to innovate, expand their offerings, and cater to the growing needs of the healthcare and life sciences sectors.
The global proteomics market is expected to grow at a CAGR of 14.7% from 2021 to 2030.
This statistic indicates that the global proteomics market is projected to experience significant growth over the next decade, with a Compound Annual Growth Rate (CAGR) of 14.7% expected from 2021 to 2030. Proteomics is the study of proteomes, the complete set of proteins produced by an organism or system, and plays a crucial role in various fields such as drug discovery, diagnostics, and personalized medicine. The projected high growth rate suggests a growing demand for proteomics technologies and services, driven by increasing research activities, technological advancements, and the expanding application of proteomics in understanding various biological processes. This growth trend signifies significant opportunities for market players and underscores the importance of proteomics in advancing our understanding of complex biological systems.
The reagents segment held the largest share of over 60.0% in the application sector of the proteomics market in 2019.
This statistic indicates that in 2019, the reagents segment made up the largest portion, accounting for over 60.0% of the total market share in the application sector of the proteomics market. This suggests that reagents played a significant role in driving the overall market growth and adoption of proteomics technologies during that period. The fact that the reagents segment held a majority share highlights the importance of these components in conducting proteomics research and analysis, showcasing their essential role in the industry’s development.
North America dominated the market for proteomics industry in 2019, occupying over 40.0% of the total revenue.
The statistic indicates that in the year 2019, the region of North America had a significant influence in the proteomics industry, capturing more than 40.0% of the overall revenue generated within the industry. This suggests that North America had a strong presence and market share in the field of proteomics during that time period, potentially leading the way in research, development, and commercialization of proteomic technologies and services. The dominance of North America could be attributed to factors such as advanced research infrastructure, strong academic and industry collaborations, and significant investments in proteomics research within the region.
The Asia Pacific proteomics market is also expected to showcase profitable growth owing to increasing R&D expenditures.
The statement suggests that the Asia Pacific proteomics market is forecasted to experience growth and generate profit in the foreseeable future, primarily due to a rise in research and development (R&D) investments. Proteomics is a field of study that involves the analysis of proteins in biological systems, which is crucial for understanding various biological processes and diseases. The increasing R&D expenditures indicate a growing interest and focus on protein-related research in the Asia Pacific region, which is likely to drive innovation and advancements in the field of proteomics. This growth is expected to result in business opportunities and economic benefits for companies operating in the proteomics market in the Asia Pacific region.
The global proteomics market for protein microarray technology is projected to grow at a CAGR of 8.9% throughout the forecast period.
This statistic indicates that the global proteomics market focusing on protein microarray technology is expected to experience a Compound Annual Growth Rate (CAGR) of 8.9% over the specified forecast period. This means that the market for protein microarray technology, used in proteomics research to study protein interactions and functions, is anticipated to expand steadily at an annual rate of 8.9%. This growth rate suggests increasing demand for protein microarray technology in proteomics studies, likely driven by advancements in research, technological developments, and potential applications across various industries such as pharmaceuticals, biotechnology, and healthcare. Overall, the projection highlights a positive outlook for the global proteomics market and indicates opportunities for growth and innovation in the field of protein microarray technology.
Clinical diagnoses accounted for the second-largest share i.e., 33.0% of the proteomics market in 2019.
This statistic indicates that clinical diagnoses accounted for a significant portion of the proteomics market in 2019, comprising 33.0% of the market share. This highlights the importance of proteomics technology in the field of clinical diagnostics, where it plays a crucial role in the identification and understanding of proteins and biomarkers associated with various diseases. The high percentage share suggests a strong demand for proteomics-based diagnostic tools and services in the healthcare industry, reflecting the growing recognition of the potential of proteomics in improving disease detection, diagnosis, and treatment strategies.
In 2019, the proteomics market for drug discovery application held a market share of 29.8%.
The statistic “In 2019, the proteomics market for drug discovery application held a market share of 29.8%” indicates that within the broader field of proteomics, a specific segment focused on drug discovery applications accounted for nearly 30% of the total market share in 2019. Proteomics involves the study of proteins and their functions within biological systems, and its applications in drug discovery are crucial for identifying potential drug targets, understanding disease mechanisms, and developing new therapeutic interventions. The significant market share held by proteomics in drug discovery signifies its importance and widespread adoption within the pharmaceutical industry as a key tool for advancing research and development efforts in the pursuit of new and improved drugs.
Europe was recognized as the second-largest regional market in 2019.
The statement “Europe was recognized as the second-largest regional market in 2019” indicates that in terms of market size or economic activity, Europe ranked as the second-largest region compared to other regions during the year 2019. This suggests that Europe played a significant role in the global economy by contributing to a substantial portion of overall market activity. Factors such as consumer demand, production, trade, and investment within Europe likely influenced its position as the second-largest regional market. This statistic provides valuable insight into the economic landscape and competitiveness of different regions in 2019.
Companies in the proteomics industry spent over USD 1.5 billion in total on research and development in 2018.
The statistic indicates that companies operating in the proteomics industry collectively invested a significant amount of over USD 1.5 billion into research and development activities during the year 2018. This expenditure reflects the industry’s commitment to advancing scientific knowledge and technological capabilities related to the study of proteins and their functions, applications, and potential therapeutic interventions. Such substantial financial investments signal a strong emphasis on innovation, competitiveness, and a drive to push the boundaries of proteomics research, potentially leading to breakthroughs in healthcare, pharmaceuticals, biotechnology, and other related fields.
The largest segment by instrument type in the proteomics market is ‘spectroscopy’.
The statement “The largest segment by instrument type in the proteomics market is ‘spectroscopy'” suggests that among all the different types of instruments used in the field of proteomics, spectroscopy instruments hold the highest proportion of market share. This indicates that spectroscopy plays a crucial role in proteomics research, likely due to its ability to analyze the structure and composition of proteins accurately and efficiently. Researchers in the proteomics field rely on spectroscopy to study the interactions, functions, and properties of proteins, making it a fundamental tool in advancing our understanding of complex biological systems at the molecular level.
The bioinformatics segment is anticipated to reflect a high CAGR of 19.2% during the forecast period.
This statistic indicates that the bioinformatics segment is projected to experience a Compound Annual Growth Rate (CAGR) of 19.2% over the forecast period. A high CAGR of 19.2% suggests significant growth potential for bioinformatics, which involves the application of computational tools and techniques to analyze biological data. This rapid growth rate is likely driven by increasing demands for advanced analytical solutions in healthcare, agriculture, genetics, and other fields that rely on bioinformatics for data processing and interpretation. Organizations operating in the bioinformatics sector may benefit from this strong growth trend, making it an attractive market for investment and development.
By the end of 2027, services/products related to proteomics are expected to reach a market valuation above US$ 22,300 Mn.
The statistic states that by the end of 2027, the market for services and products related to proteomics is anticipated to surpass a valuation of US$ 22,300 million. This suggests a considerable growth trajectory for the proteomics industry, indicating a rising demand for services and products aimed at studying proteins and their functions. This trend could be driven by advancements in technology, increasing investments in research and development within the field of proteomics, and the growing awareness of the importance of proteins in various applications such as drug development, personalized medicine, and diagnostics. The projected market valuation signifies significant opportunities for companies operating in the proteomics sector and highlights the potential for continued innovation and expansion in this area in the coming years.
The protein microarrays segment in the proteomics market recorded an approximate revenue of USD 1.5 billion in 2019.
The statistic indicates that the protein microarrays segment within the proteomics market generated around USD 1.5 billion in revenue in 2019. Proteomics involves the study of proteins within biological systems, and protein microarrays are tools used to analyze multiple proteins simultaneously on a small surface. The substantial revenue generated by this segment highlights its significance in the field of proteomics, likely driven by the increasing adoption of protein microarrays in research, drug discovery, and diagnostic applications. This statistic signals strong market demand and investment in protein microarray technologies, pointing towards continued growth and innovation within the proteomics industry.
The demand for proteomics in cancer diagnosis is anticipated to grow at 16% CAGR.
This statistic means that the demand for proteomics, which is the study of proteins in an organism or cell, particularly in the context of cancer diagnosis, is expected to increase by a compound annual growth rate (CAGR) of 16%. This suggests a significant and steady increase in the utilization of proteomics technology in diagnosing cancer over time. The growth rate highlights the escalating interest and importance of proteomics in advancing cancer diagnosis, potentially offering more sophisticated and effective tools for early detection and personalized treatment strategies in the fight against cancer.
The proteomics market in Germany is expected to witness a CAGR of 7.8% from 2018 to 2025.
The statistic indicates that the proteomics market in Germany is projected to experience a Compound Annual Growth Rate (CAGR) of 7.8% from the year 2018 to 2025. This means that the market for proteomics technologies, which involve the study of proteins in biological systems, is anticipated to grow steadily at an average annual rate of 7.8% during this period. This growth rate suggests increasing demand and adoption of proteomics technologies in various sectors such as pharmaceuticals, biotechnology, clinical diagnostics, and research institutions within Germany, reflecting potential opportunities and advancements in the field of proteomics during the forecasted years.
Protein profiling technologies accounted for the maximum contribution, generating $2.75 billion in 2017 in the proteomics market.
The statistic indicates that protein profiling technologies played a significant role in the proteomics market in 2017, contributing the highest revenue of $2.75 billion. Protein profiling technologies refer to methods and tools used to analyze and study proteins, which are essential molecules in biological systems. These technologies enable researchers to identify, quantify, and characterize proteins within a sample, offering valuable insights into biological processes and disease mechanisms. The substantial revenue generated by protein profiling technologies underscores their importance and widespread use in proteomics research, highlighting the growing interest and investment in understanding the role of proteins in various biological contexts.
Global investments in genomics and proteomics reached USD 15.85 billion in 2010.
In 2010, global investments in genomics and proteomics, which are branches of molecular biology focusing on the study of genes and proteins respectively, amounted to a substantial USD 15.85 billion. This significant financial commitment highlights the growing importance and interest in scientific research related to understanding the intricate mechanisms of genes and proteins in living organisms. The significant investment in these cutting-edge fields indicates a widespread recognition of the potential impact on various sectors like healthcare, biotechnology, and agriculture, with the aim of advancing knowledge and developing innovative tools and treatments to address complex biological challenges.
Mass spectrometry-based proteomics expected to achieve a CAGR of 3.8% by 2025.
This statistic indicates that the field of mass spectrometry-based proteomics is projected to experience a compound annual growth rate (CAGR) of 3.8% by the year 2025. Mass spectrometry-based proteomics involves the study of proteins through mass spectrometry technology, which allows for the detection and analysis of a large number of proteins within a biological sample. The projected CAGR suggests a modest but steady growth in the application and adoption of mass spectrometry-based proteomics techniques in various fields such as biomedical research, clinical diagnostics, and drug development. This growth rate indicates that the technology is likely to continue advancing and driving innovations in proteomics research over the coming years.
References
0. – https://www.www.mordorintelligence.com
1. – https://www.www.grandviewresearch.com
2. – https://www.www.futuremarketinsights.com
3. – https://www.www.ncbi.nlm.nih.gov
4. – https://www.www.marketsandmarkets.com
5. – https://www.www.alliedmarketresearch.com
6. – https://www.www.gminsights.com
